| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2123642 | European Journal of Cancer | 2012 | 9 Pages |
Abstract
Low baseline pain intensity and better PS were associated with improved overall survival, while age and comorbidity were not independent prognostic factors for patients treated with gemcitabine-based therapy.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
M.M. Vickers, E.D. Powell, T.R. Asmis, D.J. Jonker, J.F. Hilton, C.J. O'Callaghan, D. Tu, W. Parulekar, M.J. Moore,